Haleos Labs Limited (NSE:HALEOSLABS)
1,236.00
+1.40 (0.11%)
Jan 22, 2026, 10:36 AM IST
Haleos Labs Revenue
Haleos Labs had revenue of 813.68M INR in the quarter ending September 30, 2025, with 3.70% growth. This brings the company's revenue in the last twelve months to 3.38B, up 6.53% year-over-year. In the fiscal year ending March 31, 2025, Haleos Labs had annual revenue of 3.45B with 12.67% growth.
Revenue (ttm)
3.38B
Revenue Growth
+6.53%
P/S Ratio
1.11
Revenue / Employee
5.70M
Employees
592
Market Cap
3.73B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 3.45B | 387.65M | 12.67% |
| Mar 31, 2024 | 3.06B | -96.02M | -3.04% |
| Mar 31, 2023 | 3.16B | -345.11M | -9.86% |
| Mar 31, 2022 | 3.50B | 844.79M | 31.81% |
| Mar 31, 2021 | 2.66B | 48.11M | 1.84% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 549.64B |
| Aurobindo Pharma | 325.14B |
| Cipla | 279.66B |
| Zydus Lifesciences | 244.94B |
| Apollo Hospitals Enterprise | 232.65B |
| Biocon | 164.76B |
| Alkem Laboratories | 138.90B |
| Mankind Pharma | 135.46B |